Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05880251 · ClinicalTrials.gov registry record · NA

Operant Conditioning of Sensory Brain Responses to Reduce Phantom Limb Pain in People With Limb Amputation

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT05880251: Completed NA study, sponsored by VA Office of Research and Development.

NCT05880251 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05880251, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The study will investigate the application of a non-pharmacological operant conditioning approach to reduce phantom limb pain (PLP). PLP afflicts 60-90% people who have lost a limb. It can last for years and lead to drug dependence, job loss, and poor quality of life. Current non-pharmacological interventions are encouraging but limited, and their efficacy remains unclear. Limb amputation is known to lead to abnormal sensorimotor reorganization in the brain. Multiple studies have shown that PLP severity is correlated with the extent of this reorganization. The current study will train participants via realtime feedback of brain responses to promote more normal sensorimotor response, with the goal to reduce phantom limb pain.

Interventions

  • BEHAVIORAL Operant Conditioning with Peripheral Stimulation
  • BEHAVIORAL Control Group with Peripheral Stimulation Only

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-07-01
Est. Completion 2025-08-29
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05880251

The ClinicalTrials.gov registry entry for NCT05880251 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Operant Conditioning with Peripheral Stimulation is the first listed.

NCT05880251 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05880251 about?

NCT05880251 is a clinical study titled "Operant Conditioning of Sensory Brain Responses to Reduce Phantom Limb Pain in People With Limb Amputation". The study will investigate the application of a non-pharmacological operant conditioning approach to reduce phantom limb pain (PLP). PLP afflicts 60-90% people who have lost a limb. It can last for years and lead to drug dependence, job loss, and poor quality of life. Current non-pharmacological int...

What is the current status of trial NCT05880251?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-07-01. Estimated completion is 2025-08-29.

What interventions are being tested in trial NCT05880251?

The interventions under investigation include: Operant Conditioning with Peripheral Stimulation (BEHAVIORAL), Control Group with Peripheral Stimulation Only (BEHAVIORAL).

Who is sponsoring clinical trial NCT05880251?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.